Last reviewed: May 17, 2026 Last updated: May 17, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Recently, medications known as GLP-1 agonists, including Ozempic, have become increasingly popular due to their ability to support meaningful weight loss, even among individuals without diabetes
Introducing Advanced Glutathione: A True Breakthrough After years of research and development, we're proud to introduce Advanced Glutathionea revolutionary formula designed to overcome all the traditional challenges of glutathione supplementation
These combinations will leave your skin feeling bright, hydrated and protected
At the end of the study, the group with the larger dose had 30-35% more reduced glutathione in erythrocytes, lymphocytes and plasma while the smaller dose had 17% more in the blood and 29% more in erythrocytes